Are you handling hazardous drugs?

They also present ways to minimise the associated risks of exposure in order to protect nursing staff during SACT administration. For details see T. Marler-Hausen et al, Use of a closed-system drug transfer device reduces contamination with doxorubicin during bolus injection British Journal of Nursing, 2020, Vol 29, No 10. https://www.magonlinelibrary.com/doi/full/10.12968/bjon.2020.29.10.S15

The access to this article is open under MA Healthcare terms and conditions (https://www.magonlinelibrary.com/page/authors/openaccess)

Please view links below for further information:
https://info.britishjournalofnursing.com/free-downloads/oncology https://www.bbraun.co.uk/en/products-and-therapies/infusion-therapy/tevadaptor-.html

UKONS

The UK Oncology Nursing Society
Registered Address: First Floor, 10 Queen Street Place, London EC4R 1BE
Charity Commission Number: 1136972
Companies House Registration Number: 6996552
VAT Registration Number: 290 7685 64

UKONS does not own all the documents on our website and shares them for member interest. We are not responsible for the use or recommendations of these documents, and members should use them at their discretion. UKONS cannot accept liability for errors, omissions, or consequences from applying the information and makes no warranties regarding the content. Documents are for healthcare professionals only; seek professional advice before acting on any content from our site or downloaded documents.